Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
NALCROM SANOFI-AVENTIS CANADA INC Resolved 100MG Updated Report 2022-09-24 163129
METHOTREXATE INJECTION USP PFIZER CANADA ULC Actual shortage 25MG Updated Report 2022-09-24 165286
MEPRON GLAXOSMITHKLINE INC Actual shortage 750MG Updated Report 2022-09-24 170088
STIEVA-A GLAXOSMITHKLINE INC Actual shortage 0.05% Updated Report 2022-09-24 170091
BIPHENTIN ELVIUM LIFE SCIENCES Resolved 20MG Updated Report 2022-09-24 165716
BIPHENTIN ELVIUM LIFE SCIENCES Resolved 15MG Updated Report 2022-09-24 169311
ERYTHROCIN I.V. AMDIPHARM LIMITED Actual shortage 500MG Updated Report 2022-09-24 169767
ERYTHROCIN I.V. AMDIPHARM LIMITED Actual shortage 1G Updated Report 2022-09-24 169775
COTAZYM ORGANON CANADA INC. Actual shortage 35000UNIT 40000UNIT 10000UNIT Updated Report 2022-09-24 170162
COTAZYM ECS 20 ORGANON CANADA INC. Actual shortage 100000UNIT 100000UNIT 25000UNIT Updated Report 2022-09-24 170165
DILTIAZEM HYDROCHLORIDE INJECTION OMEGA LABORATORIES LIMITED Actual shortage 5MG Updated Report 2022-09-23 168218
DILTIAZEM HYDROCHLORIDE INJECTION OMEGA LABORATORIES LIMITED Actual shortage 5MG Updated Report 2022-09-23 168215
OCTREOTIDE ACETATE OMEGA OMEGA LABORATORIES LIMITED Actual shortage 100MCG Updated Report 2022-09-23 168210
DEXAMETHASONE-OMEGA OMEGA LABORATORIES LIMITED Actual shortage 4MG Updated Report 2022-09-23 167945
THIAMIJECT INJECTION - LIQ IM IV 100MG/ML OMEGA LABORATORIES LIMITED Actual shortage 100MG Updated Report 2022-09-23 167948
MESNA FOR INJECTION FRESENIUS KABI CANADA LTD Actual shortage 100MG Updated Report 2022-09-23 143148
PREGNYL ORGANON CANADA INC. Actual shortage 10000UNIT Updated Report 2022-09-23 165320
LOTEMAX BAUSCH & LOMB INC Resolved 0.5% Updated Report 2022-09-23 167974
APO-RIZATRIPTAN APOTEX INC Actual shortage 5MG Updated Report 2022-09-23 169057
MIOCHOL-E BAUSCH & LOMB INC Actual shortage 20MG Updated Report 2022-09-23 158249
APO-RIZATRIPTAN APOTEX INC Actual shortage 10MG Updated Report 2022-09-23 166439
APO-RISPERIDONE APOTEX INC Actual shortage 0.50MG Updated Report 2022-09-23 164083
RETIN-A BAUSCH HEALTH, CANADA INC. Actual shortage 0.025% Updated Report 2022-09-23 170140
APO-RISPERIDONE APOTEX INC Actual shortage 1.0MG Updated Report 2022-09-23 165677
LOPROX BAUSCH HEALTH, CANADA INC. Actual shortage 1% Updated Report 2022-09-23 169138
APO-RISPERIDONE APOTEX INC Actual shortage 0.25MG Updated Report 2022-09-23 165674
WELLBUTRIN XL BAUSCH HEALTH, CANADA INC. Resolved 300MG Updated Report 2022-09-23 165044
ACZONE BAUSCH HEALTH, CANADA INC. Resolved 5% Updated Report 2022-09-23 168924
APO-PERINDOPRIL APOTEX INC Actual shortage 2MG Updated Report 2022-09-23 165730
APO-NAPROXEN EC APOTEX INC Actual shortage 375MG Updated Report 2022-09-23 166445
APO-NAPROXEN APOTEX INC Actual shortage 500MG Updated Report 2022-09-23 169513
APO-VALPROIC ACID APOTEX INC Actual shortage 250MG New Report 2022-09-23 170115
APO-PRAVASTATIN APOTEX INC Actual shortage 20MG New Report 2022-09-23 170112
APO-BUSPIRONE APOTEX INC Actual shortage 10MG New Report 2022-09-23 170109
APO-ACETAMINOPHEN APOTEX INC Actual shortage 325MG New Report 2022-09-23 170106
APO-PERINDOPRIL-INDAPAMIDE APOTEX INC Resolved 1.25MG 4MG Updated Report 2022-09-23 168424
APO-OXAZEPAM APOTEX INC Resolved 10MG Updated Report 2022-09-23 165329
APO-ACETAMINOPHEN APOTEX INC Actual shortage 325MG Updated Report 2022-09-23 166399
APIDRA SANOFI-AVENTIS CANADA INC Actual shortage 100UNIT Updated Report 2022-09-23 163664
APO-LATANOPROST APOTEX INC Resolved 50MCG Updated Report 2022-09-23 157695
APO-RILUZOLE APOTEX INC Resolved 50MG Updated Report 2022-09-23 103385
CLINDOXYL GEL GLAXOSMITHKLINE INC Actual shortage 1% 5% New Report 2022-09-23 170085
APO-OXYCODONE CR APOTEX INC Resolved 5.0MG Updated Report 2022-09-23 165332
APO-FAMCICLOVIR APOTEX INC Resolved 250MG Updated Report 2022-09-23 164701
APO-ACETAMINOPHEN CAPLETS APOTEX INC Resolved 325MG Updated Report 2022-09-23 168041
APO-ACEBUTOLOL APOTEX INC Resolved 100MG Updated Report 2022-09-23 166598
APO-ACEBUTOLOL APOTEX INC Resolved 400MG Updated Report 2022-09-23 165314
APO-ACEBUTOLOL APOTEX INC Resolved 200MG Updated Report 2022-09-23 162899
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH APOTEX INC Resolved 500MG Updated Report 2022-09-23 166402
YASMIN 21 BAYER INC Resolved 0.03MG 3MG Updated Report 2022-09-23 169522

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
EGRIFTA THERATECHNOLOGIES INC To be discontinued 1MG New Report 2022-09-22 170025
STAXYN BAYER INC Reversed 10MG Updated Report 2022-09-19 163103
JAMP-SILDENAFIL JAMP PHARMA CORPORATION Discontinued 50.0MG New Report 2022-09-09 169006
JAMP-SILDENAFIL JAMP PHARMA CORPORATION Discontinued 25.0MG New Report 2022-09-09 169003
JAMP-RIZATRIPTAN IR JAMP PHARMA CORPORATION Discontinued 10MG New Report 2022-09-09 168998
JAMP-RIZATRIPTAN IR JAMP PHARMA CORPORATION Discontinued 10MG New Report 2022-09-09 168995
JAMP-LOSARTAN HCTZ JAMP PHARMA CORPORATION Discontinued 12.5MG 50MG New Report 2022-09-09 168990
JAMP-LOSARTAN HCTZ JAMP PHARMA CORPORATION Discontinued 12.5MG 50MG New Report 2022-09-09 168987
JAMP-LOSARTAN HCTZ JAMP PHARMA CORPORATION Discontinued 25MG 100MG New Report 2022-09-09 168984
JAMP-LOSARTAN HCTZ JAMP PHARMA CORPORATION Discontinued 25MG 100MG New Report 2022-09-09 168981